Taking a stratified approach to the prevention of Type 2 diabetes in the Asian population

Researchers from Nanyang Technological University (NTU) and their collaborators are investigating the molecular regulatory disturbances underlying development of Type 2 diabetes amongst Asian populations.

Type 2 diabetes (T2D) is a chronic disease typically characterised by the presence of adiposity, insulin resistance and impaired glucose metabolism, with the burden of diabetes especially high in Asia. This increased risk for T2D is not fully accounted for by traditional risk factors or by genetics. Recent studies have highlighted the presence of disturbances in genome regulatory mechanisms as early manifestations of T2D risk.

To address this issue, through investigation of the prospective relationships between DNA methylation and future diabetes amongst Asian populations, researchers at NTU and their collaborators aim to advance the understanding of molecular regulatory disturbances underlying the development of diabetes amongst high-risk Asian populations. They also aim to investigate the development of novel predictive molecular markers based on genomic regulatory features to identify high-risk individuals who may benefit from early intervention for diabetes prevention.

The researchers first carried out epigenome-wide association for incident T2D using baseline samples collected at enrolment for 5,709 Asian individuals, from three prospective population-based cohorts. To further explore potential genetic and environmental factors influencing methylation, the researchers used data from an independent multi-ethnic Asian population cohort with deep clinical and molecular phenotyping. This was supplemented by functional genomic analyses and fine-mapping via targeted sequencing of selected top loci. The researchers then tested the potential utility of DNA methylation for prediction of T2D via a Methylation Risk Score (MRS) approach

DNA methylation array: DNA methylation was quantified in genomic DNA from whole blood, using the Illumina® EPIC or 450K array which covered 2-3% of the epigenome. This allowed the scientists to identify genomic loci that were associated with incident T2D.

 

Whole genome bisulfite sequencing (WGBS): DNA methylation across the entire epigenome was analyzed using libraries construction with the Accel-NGS® Methyl-Seq DNA Library Kit (Swift Biosciences), and sequenced on the Illumina® NovaSeq platform. WGBS made possible the identification of correlated regions in the epigenome, which further informs the design of the targeted methylation sequencing.

 

Targeted methylation sequencing: Fine-mapping of regions of interest were interrogated by using a custom array (TWIST Biosciences). The targeted methylation sequencing allowed the researchers to investigate these regions of interest in a high resolution fashion.

 

HPC resources used: This project was allocated 1,320,959 CPU hours on NSCC Singapore’s supercomputing resources

The researchers identified 420 CpG sites across 314 independent loci to be significantly associated with incident T2D. Fine-mapping also identified multiple additional CpG sites that were more strongly predictive of T2D than evaluation based on low-coverage microarray alone.

To find out more about how NSCC’s HPC resources can help you, please contact [email protected].

NSCC NewsBytes July 2024

Other Case Studies